Hamburg, Germany, 21 February 2017:
Evotec AG is pleased to announce that LAB282, the £ 13 m (over EUR 15 m) drug discovery partnership with Oxford University, has made its first wave of awards, backing projects targeting cardiovascular diseases and infectious diseases.
Hamburg, Germany, 09 February 2017:
Evotec AG today announced that it resolved on a capital increase from its authorised capital against cash.
Hamburg, Germany - 26 January 2017: Evotec AG today announced that Cyprotex, a company wholly owned by Evotec AG, has completed the relocation of its UK operations from Macclesfield to Alderley Park.- read more